Literature DB >> 16127446

Pathological tau: a loss of normal function or a gain in toxicity?

John Q Trojanowski, Virginia M-Y Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16127446     DOI： 10.1038/nn0905-1136

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  36 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Heterogeneous Tau-Tubulin Complexes Accelerate Microtubule Polymerization.

Authors:  Xiao-Han Li; Elizabeth Rhoades
Journal:  Biophys J       Date:  2017-06-20       Impact factor: 4.033

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 4.  Tau aggregation in Alzheimer's disease: what role for phosphorylation?

Authors:  Guy Lippens; Alain Sillen; Isabelle Landrieu; Laziza Amniai; Nathalie Sibille; Pascale Barbier; Arnaud Leroy; Xavier Hanoulle; Jean-Michel Wieruszeski
Journal:  Prion       Date:  2007-01-23       Impact factor: 3.931

Review 5.  Chronic effects of mild neurotrauma: putting the cart before the horse?

Authors:  Rudy J Castellani; George Perry; Grant L Iverson
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

6.  Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.

Authors:  Maria I Fonseca; Rahasson R Ager; Shu-Hui Chu; Ozkan Yazan; Sam D Sanderson; Frank M LaFerla; Stephen M Taylor; Trent M Woodruff; Andrea J Tenner
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

7.  A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.

Authors:  Pengcheng Han; Geidy Serrano; Thomas G Beach; Richard J Caselli; Junxiang Yin; Ningning Zhuang; Jiong Shi
Journal:  J Neuropathol Exp Neurol       Date:  2017-01-01       Impact factor: 3.685

Review 8.  Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.

Authors:  Michael Voronkov; Steven P Braithwaite; Jeffry B Stock
Journal:  Future Med Chem       Date:  2011-05       Impact factor: 3.808

9.  Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy.

Authors:  Chad Dickey; Clara Kraft; Umesh Jinwal; John Koren; Amelia Johnson; Laura Anderson; Lori Lebson; Daniel Lee; Dennis Dickson; Rohan de Silva; Lester I Binder; David Morgan; Jada Lewis
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

Review 10.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.